Target intelligence / Profile preview

Proline-rich protein 3 (PRR3)

Target
PRR3
Molecular classification
Other (proline-rich non-enzymatic, non-receptor protein), Zinc finger family
01

Overview

Proline-rich protein 3 (PRR3) is a non-enzymatic, proline-rich protein encoded by the PRR3 gene and part of the zinc finger protein family. Experimental data about its specific biological function are sparse. PRR3 is suggested to possess RNA binding activity and may play a role in the modulation of antigen presentation or other aspects of immune response based on its genomic context, particularly as it is located within the MHC class I region. Some association studies have examined PRR3's involvement in immune-related conditions, but its precise biological and clinical significance remains largely uncharacterized, with no direct evidence supporting it as a therapeutic target or established biomarker[1]. There are extensive datasets showing PRR3’s associations with expression, mutations, and gene regulation but no evidence of drug targeting or direct clinical utility as a target[1]. Several alternative names exist, but "Proline-rich protein 3" is the most scientifically accurate and canonical full name[1]. No small molecules or biologicals are known to interact directly with PRR3, and no mechanisms of action for PRR3-targeting drugs have been described[1]. No major safety concerns, therapeutic challenges, or validated biomarker uses are documented.

Other names
CAT56MHC class I region proline-rich protein CAT56proline-rich polypeptide 3Em:AB014077.1Em:AB023052.2
02

Biological functions

RNA bindingPossible modulation of antigen presentationProposed role in immune response regulation[1]
03

Disease associations

Possible association with immune-mediated diseases (e.g., posited in context of ankylosing spondylitis, but direct causal/disease-modifying evidence lacking)[1]

Beyond the preview

Go deeper on Proline-rich protein 3 (PRR3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proline-rich protein 3 (PRR3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call